Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: A 19-yr review of the Swiss national reference center

Pediatric Transplantation

Volumn 16, Issue 1, 2012, Pages 50-57

  L'Huillier, A G ^a   Wildhaber, B E ^b   Belli, D C ^a   Diana, A ^a   Rodriguez, M ^a   Siegrist, C A ^a,c   Posfay Barbe, K M ^a,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

antibodies; children; immunization; liver transplantation; serology; vaccines

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBODY TITER; CHICKENPOX; CHILD; CORRELATION ANALYSIS; DIPHTHERIA; FEMALE; HAEMOPHILUS INFECTION; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION; INFECTION PREVENTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEASLES; OUTCOME ASSESSMENT; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; REVIEW; SEROLOGY; SWITZERLAND;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; QUALITY CONTROL; REGISTRIES; SEROLOGY; SWITZERLAND; TREATMENT OUTCOME; VACCINATION; VACCINES; VIRUS DISEASES;

EID: 84856020116     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01600.x     Document Type: Review

References (29)

1. Otero-Ravina F, Rodriguez-Martinez M, Selles CF, et al., Analysis of survival after liver transplantation in Galicia, Spain. Transpl Proc 2005: 37: 3913-3915. (Pubitemid 43015209)
2. Avery RK, Michaels M,. Update on immunizations in solid organ transplant recipients: What clinicians need to know. Am J Transplant 2008: 8: 9-14.
3. Weber DJ, Rutala WA,. Immunization of immunocompromised persons. Immunol Allergy Clin North Am 2003: 23: 605-634, v-vi. (Pubitemid 38030161)
4. Burroughs M, Moscona A,. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000: 30: 857-869. (Pubitemid 32250322)
5. Loinaz C, De Juanes JR, Gonzalez EM, et al., Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997: 44: 235-238. (Pubitemid 27096045)
6. Pinot de Moira A, Nardone A,. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill 2005: 10: 43-45.
7. Reinert RR,. Pneumococcal conjugate vaccines-A European perspective. Int J Med Microbiol 2004: 294: 277-294. (Pubitemid 39381965)
8. Franco E, Vitiello G,. Vaccination strategies against hepatitis A in southern Europe. Vaccine 2003: 21: 696-697. (Pubitemid 36096856)
9. Diana A, Posfay-Barbe KM, Belli DC, Siegrist CA,. Vaccine-induced immunity in children after orthotopic liver transplantation: A 12-yr review of the Swiss national reference center. Pediatr Transplant 2007: 11: 31-37. (Pubitemid 46100954)
10. Ota MO, Vekemans J, Schlegel-Haueter SE, et al., Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002: 168: 919-925. (Pubitemid 34049596)
11. Myers C, Posfay-Barbe KM, Aebi C, et al., Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland. Pediatr Infect Dis J 2009: 28: 996-1001.
12. OFSP. Plan de vaccination suisse 2010. Bull OFSP 2010: 30: 1-29.
13. Kwon CH, Suh KS, Yi NJ, et al., Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation. Pediatr Transplant 2006: 10: 479-486. (Pubitemid 43780682)
14. Avery RK, Snydman DR,. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 2002: 35: 1513-1519. (Pubitemid 36020696)
15. OFSP. Vaccination coverage in Switzerland 1999-2003 (La couverture vaccinale en Suisse de 1999-2003). Bull OFSP 2006: 19: 366-371.
16. Gershon AA, Steinberg SP, Gelb L, et al., Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 1984: 252: 355-362. (Pubitemid 14084794)
17. Gershon AA, Steinberg SP, Gelb L,. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986: 78: 757-762. (Pubitemid 16007079)
18. Gershon AA, Steinberg SP,. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989: 320: 892-897. (Pubitemid 19101593)
19. Levin MJ, Gershon AA, Weinberg A, et al., Immunization of HIV-infected children with varicella vaccine. J Pediatr 2001: 139: 305-310. (Pubitemid 32721722)
20. Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B,. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis 2006: 194: 247-255. (Pubitemid 44087197)
21. Chaves TS, Lopes MH, De Souza VAUF, et al., Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant 2005: 9: 192-196. (Pubitemid 40476847)
22. Zamora I, Simon JM, Da Silva ME, Piqueras AI,. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994: 8: 190-192. (Pubitemid 24092256)
23. Prelog M, Zimmerhackl LB,. Varicella vaccination in pediatric kidney and liver transplantation. Pediatr Transplant 2010: 14: 41-47.
24. Diaz PS, Smith S, Hunter E, Arvin AM,. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: Relation to the immunizing regimen of live attenuated varicella vaccine. J Infect Dis 1988: 158: 1245-1252. (Pubitemid 19023288)
25. Gershon AA, Steinberg SP,. Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Infect Dis 1990: 161: 661-666.
26. Reinert P, Benkerrou M, De Montalembert M, et al., Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Pediatr Infect Dis J 2007: 26: 1105-1109. (Pubitemid 350190941)
27. Lin PL, Michaels MG, Green M, et al., Safety and immunogenicity of the American Academy of Pediatrics-Recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005: 116: 160-167.
28. Gunther M, Neuhaus R, Bauer T, Jilg W, Holtz JA, Bienzle U,. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: Antibody decline and booster vaccination with conventional vaccine. Liver Transpl 2006: 12: 316-319. (Pubitemid 43273794)
29. Pfister RE, Aeschbach V, Niksic-Stuber V, Martin BC, Siegrist CA,. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: Frequent but mostly benign cardiorespiratory events. J Pediatr 2004: 145: 58-66. (Pubitemid 38962453)